Jim Simons Renaissance Technologies
AUM
$75.8B
1-Year Est. Return
50.56%
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
1 Year Est. Return
+50.56%
AUM
$75.2B
AUM Growth
+$9.1B
(+14%)
Holding
4,018
Top Buys
| 1 | +$1B | |
| 2 | +$721M | |
| 3 | +$468M | |
| 4 |
UnitedHealth
UNH
|
+$422M |
| 5 |
GE Vernova
GEV
|
+$376M |
Top Sells
| 1 | +$673M | |
| 2 | +$481M | |
| 3 | +$433M | |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$402M |
| 5 |
Palantir
PLTR
|
+$380M |
Sector Composition
| 1 | Technology | 19.59% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.51% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
NRG Energy
NRG
$31.2B
| $91.6M | 0.12% |
570,316
+449,500
|
|
||
177
CAVA Group
CAVA
$6.19B
| $91.5M | 0.12% |
1,085,956
+167,706
|
|
||
178
Las Vegas Sands
LVS
$44.8B
| $91.2M | 0.12% |
2,095,079
-359,300
|
|
||
179
AstraZeneca
AZN
$280B
| $91.1M | 0.12% |
1,303,773
+1,004,573
|
|
||
180
Dollar Tree
DLTR
$24.3B
| $90.4M | 0.12% |
912,803
+428,100
|
|
||
181
Clear Secure
YOU
$3.28B
| $89.4M | 0.12% |
3,219,359
+395,200
|
|
||
182
Brown & Brown
BRO
$26.8B
| $89M | 0.12% |
803,112
+630,112
|
|
||
183
Campbell Soup
CPB
$8.81B
| $88.4M | 0.12% |
2,884,827
+1,022,600
|
|
||
184
Zscaler
ZS
$38.7B
| $87.6M | 0.12% |
278,900
+267,018
|
|
||
185
Pinterest
PINS
$18.1B
| $87.5M | 0.12% |
2,438,786
-774,876
|
|
||
186
Gartner
IT
$16.6B
| $86.5M | 0.12% |
214,009
+126,200
|
|
||
|
BPMC
187
DELISTED
Blueprint Medicines
BPMC
| $86.5M | 0.12% |
+674,500
|
|
||
188
GSK
GSK
$97.7B
| $86.4M | 0.12% |
2,250,853
+268,700
|
|
||
189
Seagate
STX
$60.7B
| $84.5M | 0.11% |
585,293
+513,300
|
|
||
190
UBS Group
UBS
$127B
| $83.8M | 0.11% |
2,477,891
+1,386,500
|
|
||
191
Enova International
ENVA
$3.36B
| $83.7M | 0.11% |
750,537
-23,657
|
|
||
192
Tapestry
TPR
$23.8B
| $83.5M | 0.11% |
951,000
-450,000
|
|
||
193
Natera
NTRA
$33.8B
| $83.4M | 0.11% |
493,800
+146,100
|
|
||
194
Winmark
WINA
$1.52B
| $83.3M | 0.11% |
220,496
+44,965
|
|
||
195
Morningstar
MORN
$8.97B
| $83.2M | 0.11% |
265,170
+29,900
|
|
||
196
AB InBev
BUD
$119B
| $82.5M | 0.11% |
1,201,200
+279,100
|
|
||
197
EQT Corp
EQT
$37.9B
| $82.4M | 0.11% |
1,412,365
+871,000
|
|
||
198
IAMGOLD
IAG
$8.78B
| $82.2M | 0.11% |
11,189,766
-2,738,530
|
|
||
199
Edwards Lifesciences
EW
$50B
| $81.4M | 0.11% |
1,040,386
+33,786
|
|
||
200
Take-Two Interactive
TTWO
$45.8B
| $81.2M | 0.11% |
+334,239
|
|